TRAW – traws pharma, inc. (US:NASDAQ)
Stock Stats
News
Traws Pharma (NASDAQ:TRAW) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock.
Traws Pharma (NASDAQ:TRAW) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Traws Pharma (NASDAQ:TRAW) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Traws Pharma GAAP EPS of -$0.34 [Seeking Alpha]
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
Form 8-K Traws Pharma, Inc. For: Nov 21
Form 4 Traws Pharma, Inc. For: Nov 21 Filed by: Leaman John Harold
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Squadron Capital Management LLC
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Adage Capital Management, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.